Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features

Peer Review reports

Original Submission
27 Apr 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
23 May 2022	Reviewed	Reviewer Report - Giulia Varriano
5 Jun 2022	Reviewed	Reviewer Report
21 Jun 2022	Author responded	Author comments - Meng Li
Resubmission - Version 3
21 Jun 2022	Submitted	Manuscript version 3
24 Jun 2022	Reviewed	Reviewer Report - Giulia Varriano
11 Jul 2022	Reviewed	Reviewer Report
13 Jul 2022	Author responded	Author comments - Meng Li
Resubmission - Version 4
13 Jul 2022	Submitted	Manuscript version 4
Publishing
18 Jul 2022	Editorially accepted
26 Jul 2022	Article published	10.1186/s12880-022-00859-6

Back to article page